BCRX - BioCryst Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BCRX is currently covered by 9 analysts with an average price target of $16.8. This is a potential upside of $9.67 (135.62%) from yesterday's end of day stock price of $7.13.

BioCryst Pharmaceuticals's activity chart (see below) currently has 178 price targets and 142 ratings on display. The stock rating distribution of BCRX is 95.24% BUY and 4.76% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.35% with an average time for these price targets to be met of 334.07 days.

Highest price target for BCRX is $30, Lowest price target is $9, average price target is $18.56.

Most recent stock forecast was given by GENA WANG from BARCLAYS on 04-Nov-2025. First documented stock forecast 18-Feb-2014.

Currently out of the existing stock ratings of BCRX, 20 are a BUY (95.24%), 1 are a HOLD (4.76%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$9

$1.82 (25.35%)

$11

1 months 13 days ago
(04-Nov-2025)

9/13 (69.23%)

$2.24 (33.14%)

59

Buy

$18

$10.82 (150.70%)

$20

1 months 13 days ago
(04-Nov-2025)

3/16 (18.75%)

$11.24 (166.27%)

348

Buy

$30

$22.82 (317.83%)

$21

2 months 2 days ago
(15-Oct-2025)

1/3 (33.33%)

$23.19 (340.53%)

238

Buy

$27

$19.82 (276.04%)

$18

2 months 2 days ago
(15-Oct-2025)

3/14 (21.43%)

$20.19 (296.48%)

139

Buy

$15

$7.82 (108.91%)

$10

5 months 16 days ago
(01-Jul-2025)

4/5 (80%)

$6 (66.67%)

301

Show more analysts

Please expand the browser size to see the chart

What is BCRX (BioCryst Pharmaceuticals) average time for price targets to be met?

On average it took 334.07 days on average for the stock forecasts to be realized with a an average price target met ratio 53.35

Which analyst has the current highest performing score on BCRX (BioCryst Pharmaceuticals) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on BCRX (BioCryst Pharmaceuticals)?

Andrew Fein works at HC WAINWRIGHT and has 18 price targets and 18 ratings on BCRX

Which analyst is the currently most bullish on BCRX (BioCryst Pharmaceuticals)?

Andrew Fein with highest potential upside - $22.82

Which analyst is the currently most reserved on BCRX (BioCryst Pharmaceuticals)?

Justin Kim with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?